Ikgdar 500 mg Injection
431,17$
359,42$
Ikgdar 500 mg Injection is a targeted monoclonal antibody therapy that plays a vital role in managing various immune-related disorders, particularly in oncology. This innovative treatment is primarily indicated for patients battling specific types of cancer, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia, providing a promising option for those in need of effective intervention. By binding to specific proteins on the surface of cancer cells, Ikgdar helps the immune system identify and destroy malignant cells, enhancing the body's natural defense mechanisms. While this medication offers significant benefits, it is essential to be aware of potential side effects and contraindications, as it may cause severe infusion reactions or impact immune function. Patients should discuss their complete medical history with healthcare providers to ensure safe use. Regular monitoring during treatment is crucial to manage any adverse effects effectively. With its focused approach to cancer treatment, Ikgdar represents a significant advancement in the fight against these challenging conditions, empowering patients on their journey toward recovery. Always consult your healthcare professional before beginning any new treatment regimen to determine if Ikgdar is the right choice for you.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Ikgdar 500 mg injection is primarily utilized in the treatment of Non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system and can vary significantly in its severity. Administering Ikgdar 500 mg injection helps manage the symptoms and progression of NHL. By targeting cancerous cells, this medication plays a crucial role in the overall treatment strategy.
• Another important use of Ikgdar 500 mg injection is in managing rheumatoid arthritis. This chronic inflammatory condition can cause significant pain and joint damage. Ikgdar 500 mg injection works to reduce inflammation and improve joint function in affected individuals. Its therapeutic benefits can enhance the quality of life for those living with rheumatoid arthritis.
• Ikgdar 500 mg injection is also effective in treating chronic lymphocytic leukaemia (CLL), a type of blood cancer. CLL involves the accumulation of abnormal lymphocytes, leading to various complications. The administration of Ikgdar 500 mg injection aids in controlling the disease and helps to stabilize patients' conditions. This treatment option is vital for individuals seeking to manage their CLL effectively.
• Additionally, Ikgdar 500 mg injection is indicated for granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune diseases characterized by inflammation of blood vessels, which can lead to serious complications. The use of Ikgdar 500 mg injection helps to modulate the immune response and reduce vascular inflammation. This approach is essential for improving patient outcomes in these complex conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Ikgdar 500 mg Vial has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Rituximab Injection 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Ikgdar 500 mg is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Ikgdar Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Ikgdar 500 mg reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Ikgdar 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Ikgdar 500 mg Vial is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituximab Injection 500 mg. Please consult your doctor.
• Kidney: Ikgdar 500 mg is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Ikgdar 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Ikgdar 500 mg Vial is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Anti-cancer Drug Ikgdar may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituximab Injection 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.